MedPath

Multi-institutional phase II study of photodynamic therapy using ME2906 and PNL6405CIN for patients with cervical intraepithlial neoplasia

Phase 2
Conditions
cervical intraepithelial neoplasia
Registration Number
JPRN-jRCT2041190087
Lead Sponsor
Murakami Hirotake
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
75
Inclusion Criteria

1)Female patients over 20 years old when obtaining consent
2)The subjects were patients who were diagnosed with CIN2 or CIN3 based on cervical cytology and histology findings and whose lesions were confirmed macroscopically by colposcopy.
3) Patients who do not wish to receive treatment other than PDT including
4) Eastern Cooperative Oncology Group performance status; 0-1
5) Patients with adequate bone marrow function
1.White blood cell count ; >3,000/mm3
2.Platelet count ; >100,000/mm3
3.Both alanine aminotransferase and aspartate aminotransferase ; Less than twice the facility standard
4.Serum total bilirubin level ; <2.0 mg/dL
5.Blood urea nitrogen and serum creatinine; Less than 1.5 times the facility standard
6) Provision of written informed consent.

Exclusion Criteria

1) patients with AGC (atypical glandular cells), AIS (adenocarcinoma in situ), invasive squamous cell carcinoma or other cervical malignant tumor
2) patients diagnosed with UCF (Unsatisfactory colposcopic findings) or TZ type3 by colposcopy
3) patients with other cancer
4) significant cardiovascular diseases (uncontrolled hypertension, myocardial infarction, unstable angina, congestive heart failure), uncontrolled diabetes mellitus, or severe liver cirrhosis, severe renal failure
5) preexisting of sun photosensitivity
6) porphyria
7) history of treatment with PDT using porfimer sodium or talaporfin sodium
8) pregnant or nursed women, and woman want to pregnancy within this trial period
9) unwillingness to use of contraception
10) participating in other clinical trials or within 3 months after retirement of prior clinical trial
11) judged by investigator that enrollment was inappropriate for the patient

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath